Amir Abdolahi1, Geoffrey C Williams2, Curtis G Benesch3, Henry Z Wang4, Eric M Spitzer5, Bryan E Scott5, Robert C Block6, Edwin van Wijngaarden6. 1. Department of Public Health Sciences, University of Rochester Medical Center, 265 Crittenden Blvd. CU 420644, Rochester, NY 14642, United States. Electronic address: amir.abdolahi@philips.com. 2. Department of Medicine, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, United States; Department of Psychiatry, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, United States; Department of Clinical and Social Sciences in Psychology, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, United States. 3. Department of Neurology, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, United States. 4. Department of Imaging Sciences, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642, United States. 5. Department of Radiology, Rochester General Health System, 1425 Portland Ave., Rochester, NY 14621, United States. 6. Department of Public Health Sciences, University of Rochester Medical Center, 265 Crittenden Blvd. CU 420644, Rochester, NY 14642, United States.
Abstract
BACKGROUND: Recent evidence suggests that the insular cortex may play an important role in cognitive and emotional processes that facilitate drug use but it is unclear whether changes to the insula would result in sustained abstinence. To better understand the role of the insula in maintaining abstinence, we examined quitting patterns in smokers with acute damage to their insula relative to other regions. DESIGN: Prospective cohort study with 3month follow-up, beginning June 2013 and ending May 2014. SETTING: Three acute care hospitals in Rochester, NY. PARTICIPANTS: One-hundred-fifty-six current smokers hospitalized for acute ischemic stroke; 38 with insular infarctions and 118 with non-insular infarctions, assessed by 3 neuroradiologists. MEASUREMENTS: Self-reported smoking status (seven-day point prevalence and continuous abstinence), complete abstinence from any nicotine product, and disruption of smoking addiction (defined by criteria on smoking status, difficulty of quitting, and urge) were assessed at three months post-stroke. Time to relapse (in days) after discharge was also assessed. RESULTS: Insular damage was associated with increased odds of three-month continuous abstinence (OR=3.71, 95% CI: 1.59, 8.65) and complete cessation from any nicotine product (OR=2.72, 95% CI: 1.19, 6.22). Average time to relapse was longer in the insular-damaged group (17.50days, SD=19.82) relative to non-insular damage (10.42days, SD=18.49). Among quitters, insular damage was also associated with higher relative odds of experiencing a disruption of addiction compared to non-insular damage (adjusted OR=5.60, 95% CI: 1.52, 20.56). CONCLUSIONS: These findings support the potential role of the insular cortex in maintaining smoking and nicotine abstinence. Further research is needed to establish whether the insula may be a novel target for smoking cessation interventions.
BACKGROUND: Recent evidence suggests that the insular cortex may play an important role in cognitive and emotional processes that facilitate drug use but it is unclear whether changes to the insula would result in sustained abstinence. To better understand the role of the insula in maintaining abstinence, we examined quitting patterns in smokers with acute damage to their insula relative to other regions. DESIGN: Prospective cohort study with 3month follow-up, beginning June 2013 and ending May 2014. SETTING: Three acute care hospitals in Rochester, NY. PARTICIPANTS: One-hundred-fifty-six current smokers hospitalized for acute ischemic stroke; 38 with insular infarctions and 118 with non-insular infarctions, assessed by 3 neuroradiologists. MEASUREMENTS: Self-reported smoking status (seven-day point prevalence and continuous abstinence), complete abstinence from any nicotine product, and disruption of smoking addiction (defined by criteria on smoking status, difficulty of quitting, and urge) were assessed at three months post-stroke. Time to relapse (in days) after discharge was also assessed. RESULTS:Insular damage was associated with increased odds of three-month continuous abstinence (OR=3.71, 95% CI: 1.59, 8.65) and complete cessation from any nicotine product (OR=2.72, 95% CI: 1.19, 6.22). Average time to relapse was longer in the insular-damaged group (17.50days, SD=19.82) relative to non-insular damage (10.42days, SD=18.49). Among quitters, insular damage was also associated with higher relative odds of experiencing a disruption of addiction compared to non-insular damage (adjusted OR=5.60, 95% CI: 1.52, 20.56). CONCLUSIONS: These findings support the potential role of the insular cortex in maintaining smoking and nicotine abstinence. Further research is needed to establish whether the insula may be a novel target for smoking cessation interventions.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Varun Sethi; Tarek A Yousry; Nils Muhlert; Maria Ron; Xavier Golay; Claudia Wheeler-Kingshott; David H Miller; Declan T Chard Journal: J Neurol Neurosurg Psychiatry Date: 2012-07-17 Impact factor: 10.154
Authors: Juho Joutsa; Khaled Moussawi; Shan H Siddiqi; Amir Abdolahi; William Drew; Alexander L Cohen; Thomas J Ross; Harshawardhan U Deshpande; Henry Z Wang; Joel Bruss; Elliot A Stein; Nora D Volkow; Jordan H Grafman; Edwin van Wijngaarden; Aaron D Boes; Michael D Fox Journal: Nat Med Date: 2022-06-13 Impact factor: 87.241
Authors: Dean Kirson; Samantha R Spierling Bagsic; Jiayuan Murphy; Hang Chang; Roman Vlkolinsky; Sarah N Pucci; Julia Prinzi; Casey A Williams; Savannah Y Fang; Marisa Roberto; Eric P Zorrilla Journal: Neuropharmacology Date: 2022-02-02 Impact factor: 5.273
Authors: Amir Abdolahi; Geoffrey C Williams; Curtis G Benesch; Henry Z Wang; Eric M Spitzer; Bryan E Scott; Robert C Block; Edwin van Wijngaarden Journal: Nicotine Tob Res Date: 2017-06-01 Impact factor: 4.244
Authors: Sheng Zhang; Sien Hu; Lisa M Fucito; Xingguang Luo; Carolyn M Mazure; Laszlo Zaborszky; Chiang-Shan R Li Journal: Nicotine Tob Res Date: 2017-04-01 Impact factor: 4.244
Authors: Primavera A Spagnolo; Han Wang; Prachaya Srivanitchapoom; Melanie Schwandt; Markus Heilig; Mark Hallett Journal: Neuromodulation Date: 2018-10-29
Authors: R E Bernardi; K Zohsel; N Hirth; J Treutlein; M Heilig; M Laucht; R Spanagel; W H Sommer Journal: Transl Psychiatry Date: 2016-07-26 Impact factor: 6.222